ATE531693T1 - Neue heterozyklische 2-oxo-verbindungen und pharmazeutische zusammensetzungen, die diese enthalten - Google Patents
Neue heterozyklische 2-oxo-verbindungen und pharmazeutische zusammensetzungen, die diese enthaltenInfo
- Publication number
- ATE531693T1 ATE531693T1 AT04733494T AT04733494T ATE531693T1 AT E531693 T1 ATE531693 T1 AT E531693T1 AT 04733494 T AT04733494 T AT 04733494T AT 04733494 T AT04733494 T AT 04733494T AT E531693 T1 ATE531693 T1 AT E531693T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing same
- oxo compounds
- new heterocyclic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20030031451 | 2003-05-17 | ||
| KR20030031450 | 2003-05-17 | ||
| KR1020040031841A KR100594376B1 (ko) | 2003-05-17 | 2004-05-06 | 항염증 활성을 갖는 신규 2-옥소-피페리딘 유도체(2)화합물, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물 |
| KR1020040032263A KR100594377B1 (ko) | 2003-05-17 | 2004-05-07 | 항염증 활성을 갖는 신규 2-옥소-피페리딘 유도체(ⅰ)화합물, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물 |
| KR1020040033388A KR20050108187A (ko) | 2004-05-12 | 2004-05-12 | 항염증 활성을 갖는 신규 2-옥소-피롤유도체（ⅱ）화합물, 이의 제조방법 및 이를 포함하는염증 질환의 치료를 위한 조성물 |
| KR1020040033387A KR100571749B1 (ko) | 2004-05-12 | 2004-05-12 | 항염증 활성을 갖는 신규 2-옥소-피롤 유도체（ⅰ）화합물, 이의 제조방법 및 이를 포함하는 염증 질환의 치료를 위한 조성물 |
| PCT/KR2004/001169 WO2004101523A1 (en) | 2003-05-17 | 2004-05-17 | Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE531693T1 true ATE531693T1 (de) | 2011-11-15 |
Family
ID=44898347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04733494T ATE531693T1 (de) | 2003-05-17 | 2004-05-17 | Neue heterozyklische 2-oxo-verbindungen und pharmazeutische zusammensetzungen, die diese enthalten |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP4914719B2 (de) |
| AT (1) | ATE531693T1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4799408B2 (ja) * | 2003-07-15 | 2011-10-26 | コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー | 新規な２−オキソ複素環化合物およびそれを含有する薬剤組成物の使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3384625A (en) * | 1964-01-29 | 1968-05-21 | Allied Chem | Polyamide polymerization products of derivatives of epsilon-caprolactam |
| CA2250353A1 (en) * | 1996-04-03 | 1997-10-09 | Christopher J. Dinsmore | Inhibitors of farnesyl-protein transferase |
| AU4181000A (en) * | 1999-04-02 | 2000-10-23 | Du Pont Pharmaceuticals Company | Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase |
-
2004
- 2004-05-17 AT AT04733494T patent/ATE531693T1/de active
- 2004-05-17 JP JP2006532046A patent/JP4914719B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007501855A (ja) | 2007-02-01 |
| JP4914719B2 (ja) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60121813D1 (de) | Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten | |
| DE60219051D1 (de) | Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten | |
| ATE323713T1 (de) | Neue heterocyclische fluorglykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE335753T1 (de) | Glucopyranosyloxybenzylbenzol derivate und medizinische zusammensetzungen, die diese verbindungen enthalten | |
| DE50302843D1 (de) | Neue aromatische fluorglycosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| ATE434601T1 (de) | Neue amid-verbindungen mit mch-antagonistischer wirkung und diese verbindungen enthaltende arzneimittel | |
| IL174128A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| ATE395338T1 (de) | Pyrazolderivate, zusammensetzungen, die solche verbindungen enthalten, und anwendungsverfahren | |
| ATE529420T1 (de) | 3-ä(2-ää4-hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester-methansulfonat-hemihydrat und dessen verwendung als arzneimittel | |
| EP1603593A4 (de) | Pharmazeutische zusammensetzung | |
| ATE337311T1 (de) | Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten | |
| EP1425019A4 (de) | Pharmazeutische zusammensetzung | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| ATE430135T1 (de) | Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| DE602004017463D1 (de) | Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung | |
| DE602004023623D1 (de) | Chirale verbindungen und zusammensetzungen, die diese enthalten | |
| IL174249A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| EP1651651A4 (de) | Cucurbiturilderivate enthaltende nanopartikel, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
| DE602006015062D1 (de) | 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
| DE60012353D1 (de) | Polyorthoester und härtbare zusammensetzung, die diese enthalten | |
| DE60334012D1 (de) | Valerolactonverbindungen und parf mzusammensetzung | |
| DE602004016016D1 (de) | Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen | |
| DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
| DE602004016015D1 (de) | Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen |